< Back to Driven By Evidence Home

 

 

 

   

ATLAS Study: Y-stenting subset

Treat bifurcations with confidence

The ATLAS Y-stenting subset is the largest single study to date, prospectively evaluated studying Y-stenting treatments of bifurcation aneurysms.

Atlas Study: Y-stenting subset

The results are in
Y Stenting results: 60 patients; 56.7 basil artery

Although Y-stenting is typically linked to higher rates of ischemic complications, results from the ATLAS IDE study show an incredible low complication rate of 3.3%.

View Full Study
Y Stenting: 81.1% Primary effectiveness endpoint
Y Stenting: 3.3% Primary safety endpoint

Results are based on retrospective subset analysis of a single-arm trial

Source: Jadhav AP, Desai SM, Jovin TG et al. Y-Stent–Assisted Coiling of Wide-Necked Intracranial Aneurysms With the Neuroform Atlas Stent System.

Stroke Vasc Interv Neurol. 2022;0:e000437

This information is intended solely for the use of healthcare professionals.

A physician must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that physicians be trained in the use of any particular product before using it in a procedure. The information presented is intended to demonstrate the breadth of Stryker product offerings. A physician must always refer to the package insert, product label and/or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.